Polycation-based DNA complexes for tumor-targeted gene delivery in vivo
Background Efficient and target‐specific in vivo gene delivery is a major challenge in gene therapy. Compared to cell culture application, in vivo gene delivery faces a variety of additional obstacles such as anatomical size constraints, interactions with biological fluids and extracellular matrix,...
Saved in:
Published in | The journal of gene medicine Vol. 1; no. 2; pp. 111 - 120 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.03.1999
Wiley Periodicals Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Efficient and target‐specific in vivo gene delivery is a major challenge in gene therapy. Compared to cell culture application, in vivo gene delivery faces a variety of additional obstacles such as anatomical size constraints, interactions with biological fluids and extracellular matrix, and binding to a broad variety of non‐target cell types.
Methods
Polycation‐based vectors, including adenovirus‐enhanced transferrinfection (AVET) and transferrin‐polyethylenimine (Tf‐PEI), were tested for gene delivery into subcutaneously growing tumors after local and systemic application. DNA biodistribution and reporter gene expression was measured in the major organs and in the tumor.
Results
Gene transfer after intratumoral application was 10–100 fold more efficient with Tf‐PEI/DNA or AVET complexes in comparison to naked DNA. Targeted gene delivery into subcutaneously growing tumors after systemic application was achieved using electroneutral AVET complexes and sterically stabilized PEGylated Tf‐PEI/DNA complexes, whereas application of positively charged polycation/DNA complexes resulted in predominant gene expression in the lungs and was associated by considerable toxicity.
Conclusion
For systemic application, the physical and colloidal parameters of the transfection complexes, such as particle size, stability, and surface charge, determine DNA biodistribution, toxicity, and transfection efficacy. By controlling these parameters, DNA biodistribution and gene expression can be targeted to different organs. Copyright © 1999 John Wiley & Sons, Ltd. |
---|---|
Bibliography: | ark:/67375/WNG-7MNX69MJ-B ArticleID:JGM22 The European Community istex:6ACB98D50820000BD9EA7582951FC7D1D68D190E The Austrian Science Foundation ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 1099-498X 1521-2254 |
DOI: | 10.1002/(SICI)1521-2254(199903/04)1:2<111::AID-JGM22>3.0.CO;2-Y |